Mesoblast gets boost from positive FDA news in USA

MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more

Analysts give Paragon-CH2 deal a thumbs up

MELBOURNE: Analysts at Bell Potter are backing the back door listing of the ... read more

Bupa Asia PAcific navigates 2023 financial landscape with aplomb

SYDNEY: Bupa Asia Pacific has revealed its financial results for the year ending ... read more

Aspen’s Eureka takeover hits hurdle as developer lifts stake

PERTH: The battle for listed affordable accommodation provider Eureka is expected to intensify ... read more